Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma-Reference-Cited by-同舟云学术

Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma

Published:2011-11-24 Issue:6 Volume:165 Page:1197-1204
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Oh S.T.,Kim H.S.,Yoo N.J.,Lee W.S.,Cho B.K.,Reichrath J.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2011.10506.x/fullpdf

Reference48 articles.

1. Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study;Bath-Hextall;Int J Cancer,2007

2. Diagnosis of nonmelanoma skin cancer;Brodland;Clin Dermatol,1995

3. Imiquimod in the treatment of eyelid basal cell carcinoma;Leppälä;Acta Ophthalmol Scand,2007

4. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up;Schiessl;J Drugs Dermatol,2007

5. Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial;Peris;Dermatol Surg,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basal Cell Carcinoma;Rook's Textbook of Dermatology;2024-03-19

2. Expression of β-Catenin, E-Cadherin, and α-Smooth Muscle Actin in Basal Cell Carcinoma Before Photodynamic Therapy in Non-recurrent and Recurrent Tumors: Exploring the Ability of Predicting Photodynamic Therapy Outcome;Journal of Histochemistry & Cytochemistry;2023-03

3. Nodular and Micronodular Basal Cell Carcinoma Subtypes Are Different Tumors Based on Their Morphological Architecture and Their Interaction with the Surrounding Stroma;Diagnostics;2022-07-05

4. Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma;Biomolecules;2021-06-17

5. Matrix metalloproteinases in keratinocyte carcinomas;Experimental Dermatology;2020-09-17